Conjunctival microcysts density increases after canaloplasty

Article

Conjunctival microcysts density and surface area increases after canaloplasty in glaucomatous eyes.

Conjunctival microcysts density and surface area increases after canaloplasty in glaucomatous eyes, according to an investigation in the British Journal of Ophthalmology.

A team led by Dr Luca Agnifili, Department of Medicine and Ageing Science, Ophthalmic Clinic, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy, looked at 30 consecutive glaucomatous patients. Successful canaloplasty was completed if preoperative intraocular pressure (IOP) was reduced by a third.

Confocal laser-scanning microscopy was used to examine the conjunctiva one week before and 12 weeks after surgery. Outcome measures included the mean density and mean area of the conjunctival microcysts and IOP. Postoperative trabecular distension and scleral modifications were assessed using anterior segment optical coherence tomography.

Twelve weeks postoperatively, canaloplasty was successfully completed in 23 patients (Group 1) but unsuccessful in seven patients (Group 2). IOP was measured at 28.1+/-2.98 and 28.3+/-2.81 mm Hg for groups 1 and 2, respectively. Baseline IOP was 28.1+/-2.98 and 28.3+/-2.81 mm Hg, MMD was 10.61+/-4.31 and 11.35+/-5.6 and MMA was 2845.02+/-411.85 and 2700.56+/-518.85 in groups 1 and 2, respectively.

It was found that density and surface area of the conjunctival microcysts were increased. The aqueous humour filtration across the sclera and conjunctiva were enhanced after canaloplasty.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.